Abeona Therapeutics Receives Orphan Drug Designation in the European Union for EB-101
Abeona Therapeutics Inc., a leading clinical-stage biopharmaceutical company focused on developing gene therapies for life-threatening rare diseases, announced today that the European…
Read More...
Read More...
